Skip to Main Content

Author Details

Wendy Maury
Carver College of Medicine, University of Iowa
1978
88
35
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36902059Structurally Different Yet Functionally Similar: Aptamers Specific for the Ebola Virus Soluble Glycoprotein and GP1,2 and Their Application in Electrochemical Sensing.Int J Mol Sci2023
37376652CD40 Signaling in Mice Elicits a Broad Antiviral Response Early during Acute Infection with RNA Viruses.Viruses2023
36625663Epitranscriptomic <i>N</i><sup>6</sup>-Methyladenosine Profile of SARS-CoV-2-Infected Human Lung Epithelial Cells.Microbiol Spectr2023
35080430Limited Variation between SARS-CoV-2-Infected Individuals in Domain Specificity and Relative Potency of the Antibody Response against the Spike Glycoprotein.Microbiol Spectr2022
35690007Adipocytes are susceptible to Ebola Virus infection.Virology2022
35360113Human Organotypic Airway and Lung Organoid Cells of Bronchiolar and Alveolar Differentiation Are Permissive to Infection by Influenza and SARS-CoV-2 Respiratory Virus.Front Cell Infect Microbiol2022
32441445Frontline Science: CD40 signaling restricts RNA virus replication in MÏ¿s, leading to rapid innate immune control of acute virus infection.J Leukoc Biol2021
33830176Hemolysis-associated phosphatidylserine exposure promotes polyclonal plasmablast differentiation.J Exp Med2021
34555126Enveloped RNA virus utilization of phosphatidylserine receptors: Advantages of exploiting a conserved, widely available mechanism of entry.PLoS Pathog2021
34797899Phosphatidylserine receptors enhance SARS-CoV-2 infection.PLoS Pathog2021
34159331Phosphatidylserine Receptors Enhance SARS-CoV-2 Infection: AXL as a Therapeutic Target for COVID-19.bioRxiv2021
34232742A Naturally Occurring Polymorphism in the Base of Sudan Virus Glycoprotein Decreases Glycoprotein Stability in a Species-Dependent Manner.J Virol2021
32424361Infection-induced plasmablasts are a nutrient sink that impairs humoral immunity to malaria.Nat Immunol2020
32641828Envelope protein ubiquitination drives entry and pathogenesis of Zika virus.Nature2020
32209467Acute Plasmodium Infection Promotes Interferon-Gamma-Dependent Resistance to Ebola Virus Infection.Cell Rep2020
31092684TIM1 (HAVCR1): an Essential "Receptor" or an "Accessory Attachment Factor" for Hepatitis A Virus?J Virol2019
31825972IL-4/IL-13 polarization of macrophages enhances Ebola virus glycoprotein-dependent infection.PLoS Negl Trop Dis2019
31242184TIM-1 serves as a receptor for Ebola virus in vivo, enhancing viremia and pathogenesis.PLoS Negl Trop Dis2019
29875238TIM-1 Mediates Dystroglycan-Independent Entry of Lassa Virus.J Virol2018
30095866The role of mononuclear phagocytes in Ebola virus infection.J Leukoc Biol2018
30120364A 2'FY-RNA Motif Defines an Aptamer for Ebolavirus Secreted Protein.Sci Rep2018
28573610Production of Filovirus Glycoprotein-Pseudotyped Vesicular Stomatitis Virus for Study of Filovirus Entry Mechanisms.Methods Mol Biol2017
28100617Differences in Glycoprotein Complex Receptor Binding Site Accessibility Prompt Poor Cross-Reactivity of Neutralizing Antibodies between Closely Related Arenaviruses.J Virol2017
28615211Vesicular Stomatitis Virus Pseudotyped with Ebola Virus Glycoprotein Serves as a Protective, Noninfectious Vaccine against Ebola Virus Challenge in Mice.J Virol2017
28874468TIM1 (HAVCR1) Is Not Essential for Cellular Entry of Either Quasi-enveloped or Naked Hepatitis A Virions.mBio2017
28601947Mechanisms of Filovirus Entry.Curr Top Microbiol Immunol2017
28573611Lentiviral Vectors Pseudotyped with Filoviral Glycoproteins.Methods Mol Biol2017
27161622Large-Scale Screening and Identification of Novel Ebola Virus and Marburg Virus Entry Inhibitors.Antimicrob Agents Chemother2016
27122575Characterization of Human and Murine T-Cell Immunoglobulin Mucin Domain 4 (TIM-4) IgV Domain Residues Critical for Ebola Virus Entry.J Virol2016
25928849Ebola virus entry: a curious and complex series of events.PLoS Pathog2015
26509109Ebola virus entry into host cells: identifying therapeutic strategies.Curr Clin Microbiol Rep2015
26562011Interferon-γ Inhibits Ebola Virus Infection.PLoS Pathog2015
26038399The Role of Conserved N-Linked Glycans on Ebola Virus Glycoprotein 2.J Infect Dis2015
24473128Comprehensive functional analysis of N-linked glycans on Ebola virus GP1.mBio2014
25277499Phosphatidylserine receptors: enhancers of enveloped virus entry and infection.Virology2014
25136083TIM-family proteins inhibit HIV-1 release.Proc Natl Acad Sci U S A2014
24696470Characterizing functional domains for TIM-mediated enveloped virus entry.J Virol2014
23115293AMP-activated protein kinase is required for the macropinocytic internalization of ebolavirus.J Virol2013
23698310Role of the phosphatidylserine receptor TIM-1 in enveloped-virus entry.J Virol2013
23411007BST-2/tetherin-mediated restriction of chikungunya (CHIKV) VLP budding is counteracted by CHIKV non-structural protein 1 (nsP1).Virology2013
23360952Intrapulmonary Versus Nasal Transduction of Murine Airways With GP64-pseudotyped Viral Vectors.Mol Ther Nucleic Acids2013
21907253Transcutaneous DNA immunization following waxing-based hair depilation.J Control Release2012
22470835Filovirus entry: a novelty in the viral fusion world.Viruses2012
22191439Ebolavirus: a brief review of novel therapeutic targets.Future Microbiol2012
21047970The Tyro3 receptor kinase Axl enhances macropinocytosis of Zaire ebolavirus.J Virol2011
21529875Tyrosine kinase receptor Axl enhances entry of Zaire ebolavirus without direct interactions with the viral glycoprotein.Virology2011
21513560Inhibition of HIV-1 infection by aqueous extracts of Prunella vulgaris L.Virol J2011
21536871T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus.Proc Natl Acad Sci U S A2011
21306897Synthesis of chroman aldehydes that inhibit HIV.Bioorg Med Chem Lett2011
19154592Inhibition of lentivirus replication by aqueous extracts of Prunella vulgaris.Virol J2009
  • 1 - 50 of 88

Recommended Authors

Elizabeth A Nelson
Cardiovascular Research Center, University of Virginia School of Medicine
Career Start Year 2014
Number of shared co-authors 1
Maxime Chazal
CNRS UMR9, Institut Pasteur, Universite de Paris Cite
Career Start Year 2012
Number of shared co-authors 1
Craig B Wilen
Yale School of Medicine
Career Start Year 2010
Number of shared co-authors 1
Blandine Monel
Institut Pasteur, CNRS UMR 3569
Career Start Year 2009
Number of shared co-authors 1
Hans-Heinrich Hoffmann
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 0
Alexander N Freiberg
University of Texas Medical Branch
Career Start Year 2008
Number of shared co-authors 15
Jason A Wojcechowskyj
Gladstone Institutes
Career Start Year 2007
Number of shared co-authors 1
Charlotte A Stoneham
University of California
Career Start Year 2006
Number of shared co-authors 1
Jessica L Smith
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Career Start Year 2005
Number of shared co-authors 0
Nolwenn Jouvenet
CNRS UMR9, Institut Pasteur, Universite de Paris Cite
Career Start Year 2003
Number of shared co-authors 1
Birgit Bradel-Tretheway
Washington State University
Career Start Year 2000
Number of shared co-authors 0
Clare Jolly
University College London
Career Start Year 2000
Number of shared co-authors 1
Gaya K Amarasinghe
Washington University School of Medicine at St. Louis
Career Start Year 2000
Number of shared co-authors 7
Gary P Kobinger
University of Texas Medical Branch
Career Start Year 1997
Number of shared co-authors 5
Elizabeth R Fischer
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1996
Number of shared co-authors 4
J??rgen Haas
University of Edinburgh
Career Start Year 1996
Number of shared co-authors 0
Christopher F Basler
Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 10
Jan E Carette
Stanford University School of Medicine
Career Start Year 1996
Number of shared co-authors 4
Abraham L Brass
University of Massachusetts Medical School
Career Start Year 1995
Number of shared co-authors 2
Benhur Lee
Icahn School of Medicine at Mount Sinai
Career Start Year 1995
Number of shared co-authors 9
Paul D Bieniasz
The Rockefeller University
Career Start Year 1993
Number of shared co-authors 0
Alec J Hirsch
Vaccine & Gene Therapy Institute, Oregon Health & Science University
Career Start Year 1992
Number of shared co-authors 0
Stephan Becker
Institute of Virology, Philipps University Marburg
Career Start Year 1992
Number of shared co-authors 4
Vicente Planelles
University of Utah
Career Start Year 1991
Number of shared co-authors 1
James E Strong
University of Manitoba
Career Start Year 1991
Number of shared co-authors 3
Olivier Schwartz
Institut Pasteur, Universite Paris Cite, CNRS UMR9
Career Start Year 1987
Number of shared co-authors 1
Michael S Diamond
Washington University School of Medicine
Career Start Year 1982
Number of shared co-authors 11
John Guatelli
University of California San Diego, USA VA San Diego Healthcare System
Career Start Year 1978
Number of shared co-authors 2
Robert F Garry
Tulane University School of Medicine
Career Start Year 1974
Number of shared co-authors 2
Eric Hunter
Center for Family Health Research Zambia
Career Start Year 1971
Number of shared co-authors 0

Collaborators

Melinda A Brindley
Co-authored papers 11
Robert A Davey
Boston University
Co-authored papers 9
Olena Shtanko
Texas Biomedical Research Institute
Co-authored papers 4
Manu Anantpadma
Boston University
Co-authored papers 3
John D Minna
University of Texas Southwestern Medical Center at Dallas
Co-authored papers 2
Christopher B Wilson
Drukier Institute for Children's Health
Co-authored papers 1
Shannan L Rossi
Institute for Human Infection and Immunity, University of Texas Medical Branch
Co-authored papers 1
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers 1
Michael Woodson
University of Texas Medical Branch, 301 University Boulevard
Co-authored papers 1
Sara Cherry
University of Pennsylvania
Co-authored papers 1
Sarah van Tol
University of Texas Medical Branch
Co-authored papers 1
Jeffrey R Johnson
Gladstone Institutes
Co-authored papers 1
Maria I Giraldo
University of Texas Medical Branch
Co-authored papers 1
Ajit Jadhav
Co-authored papers 1
Kristin L McNally
National Institute of Allergy and Infectious Diseases
Co-authored papers 1
Holly Ramage
Sidney Kimmel Medical College, Thomas Jefferson University
Co-authored papers 1
Adam Hage
University of Texas Medical Branch
Co-authored papers 1
Baoshan Zhang
Co-authored papers 1
Douglas J LaCount
Purdue University
Co-authored papers 1
Robert F Mullins
the University of Iowa Carver College of Medicine
Co-authored papers 1
Rajarshi Guha
Vertex Pharmaceuticals
Co-authored papers 1
Marc C Morais
University of Texas Medical Branch
Co-authored papers 1
Megan E Schmidt
College of Public Health, University of Iowa
Co-authored papers 1
Hongjie Xia
University of Texas Medical Branch
Co-authored papers 1
Sonja M Best
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 1
Chao Shan
Wuhan Institute of Virology, Chinese Academy of Sciences
Co-authored papers 1
Ramon Flick
Co-authored papers 1
Ben Faga
The University of Iowa
Co-authored papers 1
Xuping Xie
University of Texas Medical Branch
Co-authored papers 1
Luis Martinez-Sobrido
Texas Biomedical Research Institute
Co-authored papers 1
Release 1.2